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Background: During the 2003 severe acute respiratory syndrome (SARS) outbreak,
many patients avoided hospital visit because of fear of infection. Antiepileptic drug
(AED) withdrawal is a risk factor for seizure recurrence. Therefore, seizure control
during the SARS outbreak is a goodmodel for examining the impact of drug withdrawal
in seizure control.
Methods: All seizures experienced by each patient before, during, and after the SARS
outbreak periods were registered in each patient’s seizure diary. The patients were
divided into four groups according to the presence of drug withdrawal as well as
seizure attack. In each group, seizures occurring during three different periods were
compared. Risk factors for seizure recurrence were also examined.
Results: Of 227 cases, 49 stopped taking medication during the outbreak. Among
them, 28 suffered seizure attacks during AED withdrawal. Four cases developed
cluster attacks and two cases had status epilepticus after AED withdrawal. AED
withdrawal produced a significant increase in seizure frequency. The major risk
factors for withdrawal seizures were symptomatic etiologies, polytherapy and non-
seizure free before AED withdrawal.
Conclusions: The SARS outbreak adversely affected seizure control because of AED
withdrawal. Patients with polytherapy, non-seizure free and symptomatic etiologies
were more susceptible to recurrence of seizures after AED withdrawal.
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According to the World Health Organization, a total
of 8477 people world wide were infected with
severe acute respiratory syndrome (SARS) during
the February to July 2003. Of these, 813 died. Duringby Elsevier Ltd. All rights reserved.
558 S.-L. Lai et al.this outbreak, a total of 664 probable cases of SARS
were reported to the Taiwan Center of Disease
Control. Among them, 71 died. On February 21,
the first identified SARS patient in Taiwan returned
from travel to China. Beginning in mid-April, unrec-
ognized cases of SARS led to a large nosocomial
cluster and subsequent SARS-associated coronavirus
transmission to health-care facilities and commu-
nity settings.1
On April 24, the Taiwan Department of Health
directed the first phase of containment: hospital
shutdown in one large municipal hospital in Taipei;
another private hospital in Taipei was shut down 5
days later.1 A patient, who visited the second Taipei
hospital to be shut down moved from Taipei to
Kaohsiung in late April and was admitted to our
Kaohsiung Chang-Gung Memorial Hospital for renal
stone. Unfortunately, she previously had been
infected with SARS at the Taipei hospital and the
virus was undiagnosed in our ward for 2 days. The
delay of diagnosis led to a large nosocomial cluster
of SARS in our hospital. The hospital closed all clinics
including the emergency department, for 18 days,
and visitors were barred. Yellow police tape barri-
caded all but one entrance to the hospital.
Medical staffs were infected during the outbreak,
and some died. The public began to avoid visits to
the doctors, nurses, pharmacies and hospitals. The
panic became so widespread that some the doctors
were shunned by neighbors when they returned to
their homes.
When nature disasters occurred, the government
and health care delivery system can quickly respond
to request for help. Regarding chronic diseases,
natural catastrophes still increase morbidity rates
for hypertension, arrhythmia, acute myocardial
infarction, and diabetes.2,3
The SARS outbreak was a difference experience.
Patients were afraid to visit hospitals, pharmacies,
and private clinics. Many patients even chose to stop
taking drugs. Noncompliancebecameamajor issue in
the management of chronic diseases. Suddenly stop-
ping medication may have a huge impact on the
treatment of many diseases. For example, uncon-
trolled seizures are amajor risk factor of mortality in
epilepsy.4,5 Sudden withdrawal of antiepileptic drug
(AED) is a risk factor for seizures,6 even status epi-
lepticus.7 Irregular anticonvulsant consumption is
worse than no therapy at all because of withdrawal
seizures8 or even suddenunexpecteddeath.9,10 Thus,
seizure control inepileptic patients is a goodexample
of the consequences of the SARS outbreak.
The aim of this study was to determine whether
drug withdrawal was a precipitating factor for sei-
zures, status epilepticus or even sudden unexpected
death during the SARS outbreak period. We furtherexamined the risk factors for drug withdrawal
induced seizures.
Methods
During the SARS outbreak period, our hospital closed
all out-patient clinic (OPDs) from May 16 to June 2,
2003. Although doctors tried to contact registered
patients, interview them by telephone, and mail
them their medications, many patients could not
be reached due to outdated or incorrect contact
information. After the SARS outbreak, the subjects
of the study and their families were interviewed
regarding their epileptic attacks before, during,
and after the SARS outbreak, specifically recording
the typeand frequencyof seizures, anywithdrawal of
medication, sleephabits andother factors associated
with seizures.
All of these epilepsy patients had undergone
neurological examinations, monitoring of antiepi-
leptic medications, electroencephalography (EEG),
and computed tomography (CT) or magnetic reso-
nance image (MRI) of the brain. Classification of
their seizures was based on their history and the
above diagnostic tools according to the 1981 classi-
fication of epileptic seizures from the International
League against Epilepsy.
In our epileptic clinic, around 300 epileptic cases
were regularly followed up in monthly basis. They
were all recruited into the study. All seizures that
occurred before, during, and after the SARS out-
break period were registered in the patient’s med-
ical history, seizure diary or both. With the help of
such a diary, a patient keeps a personal annual
registration of seizures. Unfortunately, 44 of the
271 patients did not keep seizure diaries regularly
and could not be included in the analysis of seizure
frequency. Although 10 self-report seizure free
patients of these 44 cases stopped the drug in the
SARS period, and 3 among them had seizure relapse
in drug-withdrawal period. Theywere still excluded
because of possible non-reliable seizure-free his-
tory. Nineteen new cases were also excluded
because their history of seizures did not extend to
6months prior to SARS outbreak. No cases of sudden
death were reported during the SARS period.
The definition of ‘‘before SARS outbreak’’ is the
period before our hospital closed and when patients
still had access to medication; ‘‘during SARS out-
break’’ is the period when the hospital was closed or
until the patient resumed medication after drug
withdrawal; ‘‘after SARS outbreak’’ is the period
after the SARS outbreak when the patients began to
visit the OPD and undergo follow up observation for
6 months.
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Table 1 Demographic characteristics of the patients.
Stop drug/attack Stop drug/no attack Continue drug/attack Continue drug/no attack Total
Patient number 28 21 53 125 227
Seizure etiology
Idiopathic 7 (25%) 17 (81%) 8 (15%) 51 (41%) 83
Symptomatic 21 (75%) 4 (19%) 45 (85%) 74 (59%) 144
Seizure type
Generalized 5 (18%) 11 (52%) 4 (8%) 33 (26%) 53
Partial 23 (82%) 10 (48%) 49 (92%) 92 (74%) 174
Treatment
Monotherapy 12 (43%) 16 (76%) 11 (21%) 62 (49%) 101
Multiple drugs 16 (57%) 5 (24%) 42 (79%) 63 (51%) 126
Six months before SARS
Seizure free 20 (71%) 21(100%) 2 (4%) 117 (94%) 160
Non-free 8 (29%) 0 51 (96%) 8 (6%) 67
Six months after SARS
Seizure free 17 (61%) 19 (90%) 10 (19%) 110 (88%) 156
Non-free 11 (39%) 2 (10%) 43 (81%) 15 (12%) 71
According to drug withdrawal and number of seizure attacks during the SARS period, the patients were divided into the following four
groups for comparison of the impact of SARS on seizure control: (1) ‘‘stop drug/attack’’, (2) ‘‘stop drug/no attack’’, (3) ‘‘continue
drug/attack’’, and (4) ‘‘continue drug/no attack’’. In each group, seizure etiology, seizure type, therapy, and seizure control were
listed for the comparison in different group.Seizure frequency ‘‘before SARS period’’ is the
average numbers of seizures per month during the 6
months prior to the SARS outbreak; seizure fre-
quency ‘‘during SARS period’’ is the number of
seizures during the outbreak; seizure frequency
‘‘after SARS period’’ is the average number of sei-
zures during the 6 months after the outbreak.
Theage range of the remaining227 caseswas9—93
years, mean 37.3  14.8 years. One hundred and
fifteen were males; 53 had primary generalized sei-
zures and 132 had secondarily generalized tonic—
clonic seizures; 31 had complex partial seizures
and 11 had simple partial seizures. One hundred
and one patients were on monotherapy; 93 were
on two drugs, 28 were on three drugs, and 5 were
on four drugs. To compare the risk factors for seizure
recurrence, primary generalized seizure was classi-
fied as generalized. Simple partial, complex partial,
and secondarily generalized seizures were classified
as partial. Those using only one type of drug were
classified as monotherapy; the others were classified
as polytherapy. As for the etiologies, those with
central nervous system (CNS) infection, tumor,
stroke, vascular anomaly, traumatic hemorrhage,
anddevelopmental disorderswere classified as symp-
tomatic. No etiologies were found in the idiopathic
group.
According to drug withdrawal and number of sei-
zure attacks during the SARS period, the patients
were divided into the following four groups for com-
parison of the impact of SARS on seizure control: (1)
‘‘continue drug/no attack’’, (2) ‘‘continue drug/attack’’, (3) ‘‘stop drug/no attack’’, and (4) ‘‘stop
drug/attack’’.
The seizure frequencies were analyzed by using
nonparametric Wilcoxon tests for each group during
the before-SARS outbreak in comparison to the SARS
outbreak andduring the SARS outbreak in comparison
to the after SARS outbreak. Chi-square tests were
used for comparing the differences between the
‘‘stop drug/no attack’’ and ‘‘stop drug/attack’’
groups regarding seizure etiology, seizure type, and
number of different drugs. Logistic regression was
used to analyze the risk factors for seizure recur-
rence, including age, sex, drug withdrawal, seizure
etiology, seizure types, and number of different drug
types used.
Results
During the SARS outbreak, 49 of 227 cases did not
receive medication due to loss of contact with
medical care providers. Among these cases, 28 cases
suffered seizure attacks during the outbreak. Among
them, four cases received emergency room (ER)
treatment because of cluster attacks. Two other
cases were admitted to Intensive Care Unit (ICU)
because of status epilepticus. Twenty cases, includ-
ing four sent to ER and two sent to ICU, were seizure
free for at least 6 months before SARS outbreak.
Another eight cases had seizures before the SARS
outbreak period, but the acute withdrawal of drugs
also produced a significant increase in the number of
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SARS, the 28 cases returned to the OPD, and the
drugs were reinstituted; seizure frequency then
showed a marked decrease during 6 months obser-
vation period (P < 0.001) (Fig. 1). Seventeen of the
28 cases were seizure free for 6 months. The seizure
types were 5 generalized, 10 secondarily general-
ized, 8 complex partial seizures, and 5 simple partial
seizures. The etiologies for the seizures were 7
idiopathic and 21 symptomatic including tumor,
mesial temporal sclerosis, stroke, and developmen-
tal disorders. Twelve cases received monotherapy,
and the other 16 cases had at least two drugs for
seizure control (Table 1).
Twenty-one of 227 cases did not have drugs but
they did not have seizures after drug withdrawal. All
were seizure free during the previous 6 months.
Eleven cases were generalized seizures and ten
cases were secondarily generalized seizures. The
etiologies for the seizures were 17 idiopathic, 1
stroke. Sixteen cases received monotherapy, other
five on polytherapy. After the outbreak, they kept
drug-free after the consultation. Nineteen cases
remained seizure free at the 6 months follow up
after the SARS outbreak. Another two had recurrent
seizures and they received treatment again.Figure 1 Seizure frequency changes in the group of ‘‘no
drug/attack’’. On X-axis: (1) half year period before SARS
outbreak; (2) the period during the SARS outbreak; (3) half
year period after SARS outbreak. Y-axis represent the
seizure frequency as times per month. Twenty cases were
seizure free in period 1, they had seizures ranged from one
to seven times in period 2 and the seizures were controlled
in period 3. Eight cases had one to seven seizures in period
1, they also showed frequency increase in period 2 and
seizure reduction in period 3. The difference of periods 1—
3 was significant (P < 0.001).In the above two groups, seizure type (P = 0.01,
x2-test), etiology (P = 0.001), number of drugs
(P = 0.019), and seizure free before SARS
(P = 0.007) were significantly different. Partial sei-
zure, symptomatic etiology, polytherapy, and still
seizure attack before SARS were more common in
the ‘‘stop drug/attack’’ group.
One hundred and twenty-five cases had drugs and
were seizure-free during the SARS outbreak period.
In the previous 6 months, 117 of these cases were
seizure-free for 6 months. Statistical analysis shows
seizure frequency decreased during SARS period
(P = 0.05). The seizure types in this group were 33
generalized, 12 complex partial, 2 partial, and 78
secondary generalized seizures. The etiologies for
seizures in this group were 53 idiopathic or crypto-
genic and 72 symptomatic. Sixty-two cases received
monotherapy, 49 cases received two drugs, 13
received three and 1 received four drugs.
Fifty-three cases had drugs but still suffered
seizure attacks during the SARS period. In this group,
only two cases were seizure-free in the previous 6
months. According to statistical analysis, seizure
frequency did not increase during the SARS period
(P = 0.863). The seizure types in this group were 4
generalized, 11 complex partial, 4 simple partial,
and 34 secondarily generalized seizures. The etiol-
ogies for seizures in this group were 8 idiopathic,
and 45 symptomatic. Eleven cases have treated with
monotherapy, 23 with two drugs, 15 with three
drugs, and 4 with four drugs.
In the above two groups, seizure type
(P < 0.0000), etiology (P < 0.0000), and number
of drug types (P < 0.0000), under treatment but
still seizures (P < 0.0000) differed significantly. Par-
tial seizure, symptomatic etiology, intractable sei-
zures and polytherapy were more common in the
‘‘continue drug/attack’’ group.
Analysis of risk factors by logistic regression,
shows drug withdrawal (P < 0.001), polytherapy
(P < 0.05), presence of seizure before withdrawal
(P < 0.001) and seizure etiology (P < 0.0001) were
strongly associated with seizure recurrence after
drug withdrawal.Discussion
The SARS outbreak was a severe threat to the
modern society. The uncertainty regarding how
the disease spread, and the high mortality rate
caused tremendous panic. The social and economic
influence was more severe than that of natural
disaster such as earthquake or hurricanes.
The sudden shutdown of the OPD was a great
threat to the health care delivery system for many
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by contacting scheduled patients by phone using the
patient information lists and by mailing medication
to the patients, many patients could not be con-
tacted because of incomplete or incorrect contact
information. Many patients in the ‘‘lost contact’’
group stopped taking drugs because of reluctance to
contact the hospital, and interruptions in long-term
treatment often result in seizures even status epi-
lepticus.
Among the 290 cases included in this report, no
sudden unexpected deaths were reported. In the
excluded 44 cases, the seizures reoccurred in 3 of 10
self-report seizure free cases. They were excluded
because of not keeping complete seizure record. Of
the final 227 patients analyzed, 49 cases did not
have medication. Twenty-eight of these cases suf-
fered seizures during this period. Four cases were
sent to ER because of frequent attacks and another
two because of status epilepticus. Compared to the
pre-SARS period, seizure frequency significantly
increased during the SARS period. In these cases,
the seizures were consistently controlled after anti-
epileptic drugs were re-instituted.
Previous reports have shown uncontrolled seizures
and tonic—clonic seizures increased the rate of mor-
tality4 and sudden unexpected death.9,10 Tonic—clo-
nic seizures appeared tocarry a greater risk of sudden
unexpected death than partial seizures.9,10 Fortu-
nately, no fatalities were observed among our
patients during this period. In the group of ‘‘stop
drug/attack’’, more partial seizures were noted.
Drug withdrawal and compliance failure can
cause seizures6 or even status epilepticus.7 We
observed an increased frequency of seizures and
status epilepticus in the group of ‘‘stop drug/
attack’’. The odds ratio for risk of seizures in the
drug withdrawal group is 3.14. Although 20 cases
already had been seizure-free for at least 6 months,
this group, compared to the ‘‘stop drug/no attack’’
group had more partial seizures, symptomatic etiol-
ogies, and multiple drug therapy. These findings
were in accordance with the study of risk of recur-
rence after antiepileptic drug withdrawal: ‘‘symp-
tomatic etiology is a major risk for the recurrence of
seizures’’.11
Comparing the difference between the ‘‘con-
tinue drug/no attack’’ group and ‘‘continue drug/
attack’’ group, the former group had more seizure-
free patients in the pre-SARS period. This group also
had more patients with idiopathic etiology and
monotherapy. The former group’s seizures were
more easily controlled than the latter group.
Although SARS caused great distress throughout
society, these epilepsy patients suffered excep-
tional stress. Seizure frequency in these two groupsdid not increase during the SARS period. Previous
report regarding the influence of a flooding natural
disaster on epilepsy shows stress to be significant
factor for provocation seizures.12 In the present
study, comparison of different time period showed
no evidence that stress was an aggravating factor for
their seizures in these patients.
The present study clear shows the SARS outbreak
affected othermedical diseases. The example of the
drug withdrawal effects in epilepsy patients reflexes
just one aspect of the overall impact of SARS out-
break. Other long-term diseases, such as renal fail-
ure or diabetes mellitus, might also have been
seriously affected by SARS. We can conclude from
present study that in the group of symptomatic
etiologies, still had seizure during the treatment
and polytherapy, the acute drug withdrawal will
induce recurrence of seizures.
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